• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wall Street's Most Accurate Analysts' Views On 3 Risk Off Stocks With Over 3% Dividend Yields

    5/7/24 7:48:58 AM ET
    $CALM
    $MO
    $WBA
    Farming/Seeds/Milling
    Consumer Staples
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CALM alert in real time by email

    During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

    Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.

    Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.

    Cal-Maine Foods, Inc. (NASDAQ:CALM)

    • Dividend Yield: 3.30%
    • Stephens & Co. analyst Ben Beinvenu reiterated an Equal-Weight rating with a price target of $65 on April 3, 2024. This analyst has an accuracy rate of 75%.
    • Goldman Sachs analyst Adam Samuelson maintained a Sell rating and increased the price target from $42 to $47 on March 12, 2024. This analyst has an accuracy rate of 66%.
    • Recent News: On April 4, Cal-Maine Foods said Jeff Hardin, Senior Vice President of Sales, is retiring from his position with the Company, effective July 23, 2024.

    Altria Group, Inc. (NYSE:MO)

    • Dividend Yield: 9.01%
    • Stifel analyst Matthew Smithreiterated a Buy rating with a price target of $50 on March 25. This analyst has an accuracy rate of 64%.
    • Morgan Stanley analyst Pamela Kaufman reiterated an Equal-Weight rating with a price target of $45 on July 18, 2023. This analyst has an accuracy rate of 68%.
    • Recent News: On April 25, Altria Group reported a first-quarter FY24 sales decline of 2.5% year-on-year to $5.58 billion, beating the analyst consensus estimate of $4.71 billion.

    Walgreens Boots Alliance, Inc.  (NASDAQ:WBA)

    • Dividend Yield: 5.79%
    • UBS analyst Kevin Caliendomaintained a Neutral rating and cut the price target from $25 to $22 on April 3. This analyst has an accuracy rate of 74%.
    • Morgan Stanley analyst Erin Wright maintained an Underweight rating and lowered the price target from $21 to $20 on April 1. This analyst has an accuracy rate of 73%.
    • Recent News: On April 24, DoorDash and Walgreens announced a new collaboration to offer SNAP/EBT payment at nearly 7,800 Walgreens stores across the country.

    Read More: Over $10M Bet On Sensata Technologies? Check Out These 4 Stocks Insiders Are Buying

    Get the next $CALM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CALM
    $MO
    $WBA

    CompanyDatePrice TargetRatingAnalyst
    Altria Group Inc.
    $MO
    1/9/2026$63.00Neutral → Buy
    UBS
    Cal-Maine Foods Inc.
    $CALM
    12/1/2025$100.00Buy
    The Benchmark Company
    Cal-Maine Foods Inc.
    $CALM
    8/14/2025$110.00Neutral
    Goldman
    Altria Group Inc.
    $MO
    7/9/2025$50.00Underperform
    Jefferies
    Altria Group Inc.
    $MO
    7/2/2025$59.00Sell → Neutral
    UBS
    Cal-Maine Foods Inc.
    $CALM
    5/6/2025$100.00Market Perform
    BMO Capital Markets
    Altria Group Inc.
    $MO
    4/1/2025Buy → Hold
    Deutsche Bank
    Walgreens Boots Alliance Inc.
    $WBA
    2/28/2025$11.00 → $9.00Hold → Sell
    Deutsche Bank
    More analyst ratings

    $CALM
    $MO
    $WBA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CALM
    $MO
    $WBA
    SEC Filings

    View All

    Altria Group Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ALTRIA GROUP, INC. (0000764180) (Filer)

    1/29/26 7:20:21 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - ALTRIA GROUP, INC. (0000764180) (Filer)

    1/29/26 7:04:06 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-Q filed by Cal-Maine Foods Inc.

    10-Q - CAL-MAINE FOODS INC (0000016160) (Filer)

    1/7/26 6:20:17 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    $CALM
    $MO
    $WBA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2026 Full-Year Earnings Guidance

    Altria Group, Inc. (Altria) (NYSE:MO) is participating in the Consumer Analyst Group of New York Conference in Orlando, Florida, today. Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Executive Vice President and Chief Financial Officer, will highlight the portfolio we are building to capture the growing smoke-free opportunity, discuss how we are evolving our business and capabilities to lead the U.S. nicotine space and provide more detail on our long-term growth aspirations. Remarks and Presentation The presentation will be webcast live on www.altria.com in a listen-only mode, beginning at approximately 1:00 p.m. Eastern Time. A copy of the business pr

    2/18/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Cal-Maine Foods Announces the Passing of Board Member Jim Poole, Honoring His Life and Service

    RIDGELAND, Miss., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM), the largest egg company in the United States and a leading player in the egg-based food industry, today announced with deep sadness the passing of Jim Poole, a valued member of its Board of Directors. Mr. Poole served on the Cal-Maine Foods Board since 2004, providing thoughtful leadership, steady guidance, and an unwavering commitment to the long-term success of the Company. The Board consistently valued his extensive audit and financial experience, deep risk management expertise, successful track record in business development, and broad knowledge of the general business climate in which the Company

    2/12/26 4:30:00 PM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    Altria to Present at the 2026 Consumer Analyst Group of New York Conference

    Altria Group, Inc. (Altria) (NYSE:MO) will host a webcast of its business presentation at the annual Consumer Analyst Group of New York conference in Orlando, Florida, on Wednesday, February 18, 2026, at approximately 1:00 p.m. Eastern Time. The webcast will feature a presentation by Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Executive Vice President and Chief Financial Officer. The webcast will be in a listen-only mode. Pre-event registration is necessary; directions are posted at www.altria.com/webcasts. An archived copy of the webcast will be available on altria.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260

    2/4/26 10:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $CALM
    $MO
    $WBA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Altria upgraded by UBS with a new price target

    UBS upgraded Altria from Neutral to Buy and set a new price target of $63.00

    1/9/26 8:23:08 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    The Benchmark Company initiated coverage on Cal-Maine Foods with a new price target

    The Benchmark Company initiated coverage of Cal-Maine Foods with a rating of Buy and set a new price target of $100.00

    12/1/25 8:27:17 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    Goldman initiated coverage on Cal-Maine Foods with a new price target

    Goldman initiated coverage of Cal-Maine Foods with a rating of Neutral and set a new price target of $110.00

    8/14/25 8:21:36 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    $CALM
    $MO
    $WBA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Munoz George

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    2/18/26 2:30:08 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Executive Officer Gifford William F. Jr. gifted 15,700 shares, decreasing direct ownership by 2% to 673,427 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    2/6/26 2:55:27 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Director Munoz George

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    1/20/26 5:03:46 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $CALM
    $MO
    $WBA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Strategy Officer Lombardo Keira L bought $258,599 worth of shares (2,800 units at $92.36), increasing direct ownership by 299% to 3,738 units (SEC Form 4)

    4 - CAL-MAINE FOODS INC (0000016160) (Issuer)

    10/6/25 7:46:52 PM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    Executive Chairman of Board Pessina Stefano sold $9,163,161 worth of shares (832,258 units at $11.01) and bought $9,163,161 worth of shares (832,258 units at $11.01), decreasing direct ownership by 56% to 657,308 units (SEC Form 4)

    4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

    4/29/25 8:49:21 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Bhandari Inderpal S bought $54,150 worth of shares (3,000 units at $18.05) (SEC Form 4)

    4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

    4/15/24 5:45:26 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CALM
    $MO
    $WBA
    Financials

    Live finance-specific insights

    View All

    Altria Reports 2025 Fourth-Quarter and Full-Year Results; Provides 2026 Earnings Guidance

    Altria Group, Inc. (NYSE:MO) today reports our 2025 fourth-quarter and full-year business results and provides our guidance for 2026 full-year adjusted diluted earnings per share (EPS). "2025 was a year of continued momentum for Altria, marked by strong financial performance, strategic progress across our smoke-free portfolio, new relationships in support of our long-term growth goals and significant cash returns to shareholders," said Billy Gifford, Altria's Chief Executive Officer. "For the full year, we grew adjusted diluted earnings per share by 4.4% and returned $8 billion to shareholders through dividends and share repurchases combined." "We expect to deliver 2026 full-year adjust

    1/29/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Cal-Maine Foods Reports Second Quarter Fiscal 2026 Results

    RIDGELAND, Miss., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM) ("Cal-Maine Foods," "we," "us," "our" or the "company"), the largest egg company in the United States and a leading player in the egg-based food industry, today reported results for its fiscal 2026 second quarter, ended November 29, 2025. Unless otherwise indicated, all comparisons are to the comparable period of fiscal 2025. Strategic Execution Highlights Continued focus on sales diversification and mix shift, expected to strengthen earnings durability and predictability over time In the second quarter of fiscal 2026 Shell egg sales represented 84.4% of total net sales, down 1,030 basis pointsSpeci

    1/7/26 6:00:00 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    Cal-Maine Foods Schedules Second Quarter Fiscal 2026 Earnings Release, Conference Call and Webcast

    RIDGELAND, Miss., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM), the largest egg company in the United States and a leading player in the egg-based prepared food industry, today announced it will report results for its fiscal 2026 second quarter at approximately 6:00 a.m. ET on Wednesday, January 7, 2026. The earnings release will be available on the Cal-Maine Foods website at https://www.calmainefoods.com/press-releases. Management will review the results during a conference call and webcast at 9:00 a.m. ET the same day. Participants can access the live webcast on the Investor Relations page of the Cal-Maine Foods website at https://www.calmainefoods.com/events-pr

    12/16/25 5:00:00 PM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    $CALM
    $MO
    $WBA
    Leadership Updates

    Live Leadership Updates

    View All

    Altria Group, Inc. Announces Retirement of CEO Billy Gifford and Appointment of Sal Mancuso as Successor

    Altria Group, Inc. (Altria) (NYSE:MO) announces today that Billy Gifford, Altria's Chief Executive Officer (CEO), has decided to retire, effective May 14, 2026 at the conclusion of the 2026 Annual Meeting of Shareholders (2026 Annual Meeting). Billy has had a distinguished career of over 30 years with the Altria family of companies and has served as Altria's CEO since 2020. Altria's Board of Directors (Board) has elected Salvatore (Sal) Mancuso to serve as Altria's CEO upon Billy's retirement. To facilitate a smooth transition, Billy plans to serve as a consultant to Altria upon his retirement through at least the end of 2026. Additionally, the Board elected Heather Newman to serve as Altri

    12/11/25 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group, Inc. Announces Retirement of Director George Muñoz from Board of Directors

    Altria Group, Inc. (Altria) (NYSE:MO) -- George Muñoz, a director of Altria since 2004, notified Altria of his decision to retire from service on our Board of Directors (Board) following the completion of his current term. Consequently, Mr. Muñoz will not stand for re-election to our Board at our 2026 Annual Meeting of Shareholders, which Altria anticipates holding on May 14, 2026. "George has made extensive and significant contributions to Altria over more than 20 years," said Kathryn McQuade, Altria's independent Chair of the Board. "We thank George for his long-standing and valuable service and wish him the very best upon his retirement." Mr. Muñoz is Chair of the Compensation and Ta

    10/9/25 8:35:00 AM ET
    $LAUR
    $MO
    Other Consumer Services
    Real Estate
    Medicinal Chemicals and Botanical Products
    Health Care

    Walgreen Co. To Operate as Private Standalone Company Following Acquisition By Sycamore Partners

    Appoints Mike Motz as Chief Executive Officer Walgreen Co. ("Walgreens", or the "Company"), America's leading independent retail pharmacy, announced today that it is now operating as a private standalone company following its acquisition by Sycamore Partners ("Sycamore"), a leading private equity firm based in New York. Sycamore is acquiring the business in partnership with Stefano Pessina and his family, who have reinvested 100% of their interests in Walgreens, demonstrating their ongoing support and confidence in the Company's future. Mike Motz has been appointed as Chief Executive Officer of Walgreens effective immediately. Motz was formerly CEO of Staples US Retail, a Sycamore por

    8/28/25 8:31:00 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CALM
    $MO
    $WBA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Walgreens Boots Alliance Inc.

    SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)

    10/18/24 12:45:41 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Walgreens Boots Alliance Inc.

    SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)

    8/20/24 4:05:58 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by Walgreens Boots Alliance Inc. (Amendment)

    SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)

    2/13/24 5:17:30 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples